A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type A

Laryngoscope

Volumn 124, Issue 2, 2014, Pages 413-417

  Guardiani, Elizabeth ^a   Sadoughi, Babak ^a   Blitzer, Andrew ^a   Sirois, David ^b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

Author keywords

Botulinum toxin; Facial pain; trigeminal neuralgia

Indexed keywords

BOTULINUM TOXIN A; PLACEBO; MUSCLE RELAXANT AGENT;

ALLODYNIA; FACE PAIN; FACIAL NERVE PARALYSIS; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TRIGEMINUS NEURALGIA; VISUAL ANALOG SCALE; ALGORITHM; TRIGEMINAL NEURALGIA;

ALGORITHMS; BOTULINUM TOXINS, TYPE A; HUMANS; NEUROMUSCULAR AGENTS; TRIGEMINAL NEURALGIA;

EID: 84892910373     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24286     Document Type: Review

References (19)

1. Garza I, Swanson J, Cheshire W, et al. Headache and Other Craniofacial Pain. In:, Daroff R, Fenichel G, Jankovic J, Mazziotta J, eds. Bradley's Neurology in Clinical Practice 6th ed. Philadelphia, PA: Elsevier; 2012: 1703-1744.
2. Miller JP, Acar F, Burchiel KJ,. Classification of trigeminal neuralgia: clinical, therapeutic and prognostic implications in a series of 144 patients undergoing microvascular decompression. J Neurosurg 2009; 111: 121-124.
3. Binder WF, Brin MF, Blizter A, Schoenrock LD, Pogoda JM,. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg 2000; 123: 669-676.
4. Aoki, KR,. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 2005; 26: 785-793.
5. Sirois D, Epler M, Toufani M, Blitzer A,. Botulinum toxin-A in trigeminal neuralgia: outcome of placebo-controlled RCT. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 112: e130.
6. Wu CJ, Lian YJ, Zheng YK, Zhang HF, Chen Y, Xie NC, Wang LJ,. Botulinum toxin type A for the treatment of trigeminal neuralgia: Results from a randomized, double-blind, placebo controlled trial. Cephalagia 2012; 32: 443-450.
7. Bohluli B, Motamedi MH, Bagheri SC, et al. Use of Botulinum toxin type A for drug-refractory trigeminal neuralgia: preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 111: 47-50.
8. Zuniga C, Diaz S, Piedmonte F, Micheli F,. Beneficial Effects of botulinum toxin type A in trigeminal neuralgia. Arquivos de Neuro-Psiquiatria 2008; 66: 500-503.
9. Piovesan EF, Teive HG, Kowacs PA, Coletta D, Werneck LC, Silberstein SD,. An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology 2005; 65: 1306-1308.
10. Borodic G, Acquadro M,. The use of botulinum toxin for the treatment of chronic facial pain. J Pain 2002; 3: 21-27.
11. Turk U,., Ilhan S,., Alp R,., Sur H,. Botulinum toxin and intractable trigeminal neuralgia. Clin Neuropharmacol 2005; 28: 161-162.
12. Welch MJ, Purkiss JR, Foster KA,. Sensitivity of embryonic rate dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 2000; 38: 245-258.
13. Durham PL, Cady R, Cady R,. Regulation of Calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache 2004; 44: 35-42.
14. Ranoux D, Attal N, Morain F, Bouhassira D,. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol 2008; 64: 274-283.
15. Framptom JE,. OnabotulinumtoxinA (BOTOX): a review of its use in the prophylaxis of headaches in adults with chronic migraine. Drugs 2012; 72: 825-845.
16. Fallah HM, Currimboy S,. Use of botulinum toxin A for treatment of myofascial pain and dysfunction. J Oral Maxillofac Surg 2012; 79: 1243-1245.
17. Gazerani P, Pedersen N, Staahl C, Drewes A, Arendt-Nielsen L,. Subcutaneous Botulinum Toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin. Pain 2009; 141: 60-69.
18. Habiff T,. Priniciples in diagnosis and anatomy. In:, Habiff T, ed. Clinical dermatology. Philadelphia, PA: Elsevier Inc; 2010: 1-17.
19. Gronseth G, Cruccu G, Alksne J, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology 2008; 71: 1183-1190.